| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.23 | 2e-07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.096 | 0.05 |